Leonard Osser - Milestone Scientific CEO and Director

MLSS Stock  USD 0.79  0.02  2.60%   

CEO

Mr. Leonard A. Osser serves as Interim Chief Executive Officer, Director of the Company. He was Chief Executive Officer, Director of Milestone Scientific Inc. Prior to that, he served as Milestones Chairman from 1991 until September of 2009, and during that time, from 1991 until 2007, was also Chief Executive Officer of Milestone. In September 2009, he resigned as Chairman of Milestone, but remained a director, and assumed the position of Chief Executive Officer. From 1980 until the consummation of Milestones public offering in November 1995, Mr. Osser was primarily engaged as the principal owner and Chief Executive Officer of U.S. Asian Consulting Group, Inc., a New Jerseybased provider of consulting services specializing in distressed or turnaround situations in both the public and private markets since 2017.
Age 77
Tenure 7 years
Address 425 Eagle Rock Avenue, Roseland, NJ, United States, 07068
Phone973 535 2717
Webhttps://www.milestonescientific.com
Osser’s knowledge of our business and background with us since 1980 provides the Board with valuable leadership skills and insight into our business.

Milestone Scientific Management Efficiency

The company has return on total asset (ROA) of (0.3634) % which means that it has lost $0.3634 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.594) %, meaning that it created substantial loss on money invested by shareholders. Milestone Scientific's management efficiency ratios could be used to measure how well Milestone Scientific manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.65 in 2024. Return On Capital Employed is likely to drop to -0.9 in 2024. At this time, Milestone Scientific's Other Current Assets are comparatively stable compared to the past year. Net Tangible Assets is likely to gain to about 19.4 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 548.2 K in 2024.
Milestone Scientific currently holds 395.98 K in liabilities with Debt to Equity (D/E) ratio of 0.05, which may suggest the company is not taking enough advantage from borrowing. Milestone Scientific has a current ratio of 3.87, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Milestone Scientific's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 5 records

CEO Age

Dolev RafaeliSTRATA Skin Sciences
60
Michael StewartSTRATA Skin Sciences
67
Michael WestOncoCyte Corp
71
Richard DiiorioInfuSystems Holdings
49
Ronald AndrewsOncoCyte Corp
64
Milestone Scientific Inc. designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Livingston, New Jersey. Milestone Scientific operates under Medical Instruments Supplies classification in the United States and is traded on AMEX Exchange. It employs 26 people. Milestone Scientific (MLSS) is traded on NYSE MKT Exchange in USA. It is located in 425 Eagle Rock Avenue, Roseland, NJ, United States, 07068 and employs 17 people. Milestone Scientific is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Milestone Scientific Leadership Team

Elected by the shareholders, the Milestone Scientific's board of directors comprises two types of representatives: Milestone Scientific inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Milestone. The board's role is to monitor Milestone Scientific's management team and ensure that shareholders' interests are well served. Milestone Scientific's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Milestone Scientific's outside directors are responsible for providing unbiased perspectives on the board's policies.
James JD, Senior Development
Jan Haverhals, CEO President
James McAvinn, Senior Vice President - Sales & Marketing
Leonard Osser, CEO and Director
Andy Molnar, Senior Dental
Keisha Harcum, Controller

Milestone Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Milestone Scientific a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Milestone Stock Analysis

When running Milestone Scientific's price analysis, check to measure Milestone Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Scientific is operating at the current time. Most of Milestone Scientific's value examination focuses on studying past and present price action to predict the probability of Milestone Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Scientific's price. Additionally, you may evaluate how the addition of Milestone Scientific to your portfolios can decrease your overall portfolio volatility.